Articles

T. Lambin, A. Amiot, J.M. Gornet, P. Seksik, D. Laharie, E. Louis, C. Giletta, J. Filippi, M. Fumery, G. Cadiot, G. Pineton de Chambrun, S. Nahon, M. Serrero, B. Coffin, L. Plastaras, S. Viennot,…

IMPACT OF AN EDUCATION PROGRAM ON IBD PATIENT’S SKILLS: RESULTS OF A RANDOMIZED CONTROLLED MULTICENTER STUDY (ECIPE)

J. Moreau, L. Marthey, C. Trang, M. Nachury, R. Altwegg, J.-C. Grimaud, S. Orempuller, J. Filippi, A. Aubourg, C. Baudry,P. Seksik, X. Roblin, S. Nahon, G. Savoye, B. Mesnard,C. Stefanescu, M. Simon, B. Coffin,…

Surgery for Crohn’s disease during pregnancy: A nationwide survey

Germain A, Chateau T, Beyer-Berjot L, Zerbib P, Lakkis Z, Amiot A, Buisson A, Laharie D, Lefevre JH, Nancey S, Stefanescu C, Bresler L, Peyrin-Biroulet L (United European Gastroenterol J. 2020 Jul;8(6):736-740 – PMID: 32326876)…

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn’s Disease

Bouguen G, Huguet A, Amiot A, Viennot S, Cholet F, Nachury M, Flamant M, Reimund JM, Desfourneaux V, Boureille A, Siproudhis L (Clin Gastroenterol Hepatol. 2020 Mar;18(3):628-636 – PMID: 31128337) https://pubmed.ncbi.nlm.nih.gov/31128337/

Dose De-Escalation to Adalimumab 40 Mg Every Three Weeks in Patients With Inflammatory Bowel disease-A Multicenter, Retrospective, Observational Study

Lieven Pouillon , Anne Lamoureux , Guillaume Pineton de Chambrun , Lucine Vuitton , Benjamin Pariente , Camille Zallot , Gaspard Dufour , Mathurin Fumery , Cédric Baumann , Aurélien Amiot , Stéphane Nancey…

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.

Pellet G, Stefanescu C, Carbonnel F, Peyrin-Biroulet L, Roblin X, Allimant C, Nachury M, Nancey S, Filippi J, Altwegg R, Brixi H, Fotsing G, de Rosamel L, Shili S, Laharie D (Clin Gastroenterol Hepatol.…

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

Amiot A, Filippi J, Abitbol V, Cadiot G, Laharie D, Serrero M, Altwegg R, Bouhnik Y, Peyrin-Biroulet L, Gilletta C, Roblin X, Pineton de Chambrun G, Vuitton L, Bourrier A, Nancey S, Gornet JM,…

Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients

Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, Armengol-Debeir L, Buisson A, Tran-Minh ML, Zallot C, Fumery M, Bouguen G, Abitbol V, Viennot S, Chanteloup E, Rajca S, Dib N,…

Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study.

Martin A, Nachury M, Peyrin-Biroulet L, Bouhnik Y, Nancey S, Bourrier A, Serrero M, Fumery M, Buisson A, Laharie D, Gilletta C, Filippi J, Allez M, Bouguen G, Roblin X, Altwegg R, Dib N,…

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease

Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario…

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

Pineton de Chambrun G, Amiot A, Bouguen G, Viennot S, Altwegg R, Louis E, Collins M, Fumery M, Poullenot F, Armengol L, Buisson A, Abitbol V, Laharie D, Seksik P, Nancey S, Blanc P,…

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease

Dreesen E, Baert F, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Oldenburg B, Pariente B, Pierik M, van der Woude CJ, D’Haens G, Vermeire S, Gils A (Clin Gastroenterol…

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

Lair-Mehiri L, Stefanescu C, Vaysse T, Laharie D, Roblin X, Rosa I, Treton X, Abitbol V, Amiot A, Bouguen G, Dib N, Fumery M, Pariente B, Carbonnel F, Peyrin-Biroulet L, Simon M, Viennot S,…

Efficacy and safety of golimumab in Crohn’s disease: a French national retrospective study

Martineau C, Flourié B, Wils P, Vaysse T, Altwegg R, Buisson A, Amiot A, de Chambrun GP, Abitbol V, Fumery M, Hébuterne X, Viennot S, Laharie D, Beaugerie L, Nancey S, Sokol H (Aliment…

Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn’s Disease

Bossuyt P, Dreesen E, Rimola J, Devuysere S, De Bruecker Y, Vanslembrouck R, Laurent V, Zappa M, Savoye-Collet C, Pariente B, Filippi J, Baert F, D’haens G, Laharie D, Peyrin-Biroulet L, Vermeire S (Aliment…

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

Carbonnel F, Colombel JF, Filippi J, Katsanos KH, Peyrin-Biroulet L, Allez M, Nachury M, Novacek G, Danese S, Abitbol V, Bossa F, Moreau J, Bommelaer G, Bourreille A, Fumery M, Roblin X, Reinisch W,…

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F,…

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…

Long-term Follow-up After Ileorectal Anastomosis for Ulcerative Colitis: A GETAID/GETAID Chirurgie Multicenter Retrospective Cohort of 343 Patients.

Uzzan M, Cosnes J, Amiot A, Gornet JM, Seksik P, Cotte E, Tiret E, Panis Y, Treton X. (Ann Surg . 2017 Dec;266(6):1029-1034 – PMID: 27655238) https://pubmed.ncbi.nlm.nih.gov/27655238/

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients.

Simon M, Cosnes J, Gornet JM, Seksik P, Stefanescu C, Blain A, Pariente B, Nancey S, Vuitton L, Nachury M, D’Haens G, Filippi J, Chevret S, Laharie D (J Crohns Colitis. 2017 Jan;11(1):47-52 –…

Anti-TNF therapy for genital fistulas in female patients with Crohn’s disease: a nationwide study from the Groupe d’Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).

Le Baut G, Peyrin-Biroulet L, Bouguen G, Gornet JM, Stefanescu C, Amiot A, Laharie D, Altwegg R, Fumery M, Trang C, Vuitton L, Simon M, Gilletta de Saint Joseph C, Nahon S, Caillo L,…

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d’Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).

Charlotte Gagnière , Anne Bourrier , Philippe Seksik , Jean-Marc Gornet , Olivier DeWit , Stephane Nancey , Romain Altwegg , Vered Abitbol , David Laharie , Catherine Reenaers , Anthony Buisson , Benjamin…

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Geert D’Haens , Severine Vermeire , Guy Lambrecht , Filip Baert , Peter Bossuyt , Benjamin Pariente , Anthony Buisson , Yoram Bouhnik, Jérôme Filippi , Janneke Vander Woude , Philippe Van Hootegem ,…

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn’s disease patients: a multicentre experience.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Serrero M, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V,…

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.

Tadbiri S, Peyrin-Biroulet L, Serrero M, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…

Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn’s Disease in Sustained Remission.

Reenaers C, Mary JY, Nachury M, Bouhnik Y, Laharie D, Allez M, Fumery M, Amiot A, Savoye G, Altwegg R, Devos M, Malamut G, Bourreille A, Flourie B, Marteau P, Vuitton L, Coffin B,…

Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

Lorenzo D, Maire F, Stefanescu C, Gornet JM, Seksik P, Serrero M, Bournet B, Marteau P, Amiot A, Laharie D, Trang C, Coffin B, Bellaiche G, Cadiot G, Reenaers C, Racine A, Viennot S,…

Efficacy of adalimumab in patients with Crohn’s disease and symptomatic small bowel stricture: a multicentre observational cohort (CREOLE) study.

Yoram Bouhnik , Franck Carbonnel , David Laharie , Carmen Stefanescu , Xavier Hébuterne , Vered Abitbol , Maria Nachury , Hedia Brixi , Arnaud Bourreille , Laurence Picon , Anne Bourrier , Matthieu…

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Moussata D, Allez M, Cazals-Hatem D, Treton X, Laharie D, Reimund JM, Bertheau P, Bourreille A, Lavergne-Slove A, Brixi H, Branche J, Gornet JM, Stefanescu C, Moreau J, Marteau P, Pelletier AL, Carbonnel F,…

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.

Caron B, Peyrin-Biroulet L, Pariente B, Bouhnik Y, Seksik P, Bouguen G, Caillo L, Laharie D, Carbonnel F, Altwegg R, Reenaers C, Serrero M, Trang-Poisson C, Nancey S, Filippi J, Abitbol V, Savoye G,…

Adalimumab for Patients With Crohn’s Disease Complicated by Intra-Abdominal Abscess: A Multicentre, Prospective, Observational Cohort Study

G Pineton de Chambrun , B Pariente , P Seksik , R Altwegg , L Vuitton , C Stefasnescu , S Nancey , A Aubourg , M Serrero , L Peyrin-Biroulet , J Filippi…

Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in ulcerative colitis (UC): no relationship with disease activity.

Articles,2000

Reumaux D, Colombel JF, Masy E, Duclos B, Heresbach D, Belaïche J, Cortot A, Duthilleul P (Inflamm Bowel Dis. 2000 Nov;6(4):270-4 – PMID: 11149558) https://pubmed.ncbi.nlm.nih.gov/11149558/

Serum calprotectin as a biomarker for Crohn’s disease.

Articles,2013

Meuwis MA, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Piver E, Seidel L, Colombel JF, Louis E (J Crohns Colitis. 2013 Dec;7(12):e678-83. – PMID: 23845231) https://pubmed.ncbi.nlm.nih.gov/23845231/

Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.

Zéphir H, Gower-Rousseau C, Salleron J, Simon O, Debouverie M, Le Page E, Bouhnik Y, Lebrun-Frenay C, Papeix C, Vigneron B, Allez M, Prin L, Cosnes J, Vermersch P, Colombel JF (Mult Scler. 2014…

Structural robustness of the gut mucosal microbiota is associated with Crohn’s disease remission after surgery

Mondot S, Lepage P, Seksik P, Allez M, Tréton X, Bouhnik Y, Colombel JF, Leclerc M, Pochart P, Doré J, Marteau P (Gut. 2016 Jun;65(6):954-62. – PMID: 26628508) https://pubmed.ncbi.nlm.nih.gov/26628508/

Reproducibility of colonoscopic findings in Crohn’s disease: a prospective multicenter study of interobserver variation. Groupe d’Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

Articles,1987

(Dig Dis Sci. 1987 Dec;32(12):1370-9. – PMID: 3319454) https://pubmed.ncbi.nlm.nih.gov/3319454/

Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy.

Articles,2010

Rahier JF, Buche S, Peyrin-Biroulet L, Bouhnik Y, Duclos B, Louis E, Papay P, Allez M, Cosnes J, Cortot A, Laharie D, Reimund JM, Lémann M, Delaporte E, Colombel JF (Clin Gastroenterol Hepatol. 2010…

Efficacy of a third anti-TNF monoclonal antibody in Crohn’s disease after failure of two other anti-TNF

Articles,2010

Allez M, Mozziconacci N, Vermeire S, Laharie D, Louis E, Bigard MA, Hebuterne X, Bouhnik Y, Kohn A, van Assche G, Lemann M, Rutgeerts P, Colombel JF. (Aliment Pharmacol Ther ; 2010 Jan;31(1):92-101 –…

Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.

Articles,2011

Leblanc S, Allez M, Seksik P, Flourie B, Peeters H, Dupas JL, Bouguen G, Peyrin-Biroulet L, Duclos B, Bourreille A, Dewit O, Bouhnik Y, Michetti P, Chaussade S, Saussure P, Mary JY, Colombel JF,…

Maintenance of Remission Among Patients with Crohn’s Disease on Anti-Metabolite Therapy after Infliximab Therapy is Stopped.

Articles,2012

Louis E, Mary JY, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Porcher R, Paintaud G, Piver E,…

Long-term outcome of enterocutaneous fistula in patients with Crohn’s disease treated with anti-TNF therapy: a cohort study from the GETAID.

Amiot A, Setakhr V, Seksik P, Allez M, Treton X, De Vos M, Laharie D, Colombel JF, Abitbol V, Reimund JM, Moreau J, Veyrac M, Flourie B, Cosnes J, Lemann M, Bouhnik Y. (Am…

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.

Seirafi M, de Vroey B, Amiot A, Seksik P, Roblin X, Allez M, Peyrin-Biroulet L, Marteau P, Cadiot G, Laharie D, Boureille A, De Vos M, Savoye G, Rahier JF, Carbonnel F, Bonaz B,…

Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study.

Tauber M, Buche S, Reygagne P, Berthelot JM, Aubin F, Ghislain PD, Cohen JD, Coquerelle P, Goujon E, Jullien D, Brixi H, Jeudy G, Guennoc X, Martin A, Brénaut E, Hoppé E, Bertolotti A,…

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’s disease

Rajca S, Grondin V, Louis E, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Paintaud G, Piver E,…

Standardizing terms definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium.

Articles,2015

B Rup , M Pallardy , D Sikkema , T Albert , M Allez , P Broet , C Carini , P Creeke , J Davidson , N De Vries , D Finco ,…

Costs of Crohn’s Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

Boschetti G, Nancey S, Daniel F, Pariente B, Lerebours E, Duclos B, Bourreille A, Cadiot G, Fumery M, Moreau J, Marteau P, Bouhnik Y, Louis E, Flourie B (Inflamm Bowel Dis. 2016 Dec;22(12) –…

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.

Abitbol Y, Laharie D, Cosnes J, Allez M, Nancey S, Amiot A, Aubourg A, Fumery M, Altwegg R, Michetti P, Chanteloup E, Seksik P, Baudry C, Flamant M, Bouguen G, Stefanescu C, Bourrier A,…

Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn’s Disease.

Marteau P, Laharie D, Colombel JF, Martin L, Coevoet H, Allez M, Cadiot G, Bourreille A, Carbonnel F, Bouhnik Y, Coffin B, Duclos B, Dupas JL, Moreau J, Louis E, Mary JY (J Crohns…

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.

Poullenot F, Seksik P, Beaugerie L, Amiot A, Nachury M, Abitbol V, Stefanescu C, Reenaers C, Fumery M, Pelletier AL, Nancey S, Peyrin-Biroulet L, Bourreille A, Hébuterne X, Brixi H, Savoye G, Lourenço N,…

Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial.

Senéjoux A, Siproudhis L, Abramowitz L, Munoz-Bongrand N, Desseaux K, Bouguen G, Bourreille A, Dewit O, Stefanescu C, Vernier G, Louis E, Grimaud JC, Godart B, Savoye G, Hebuterne X, Bauer P, Nachury M,…

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti-Tumor Necrosis Factor Agents.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Grimaud JC, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V,…

Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature.

Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas…

Clinical characteristics of Crohn’s disease in 72 families. Gastroenterology.

Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Belaiche J, Hostein J, Hugot JP, van Kruiningen H, Cortot A. (1996 Sep;111(3):604-7.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8780563&query_hl=26&itool=pubmed_DocSum

Mesalamine in Crohn’s disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives.

Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, Duclos B, Soule JC, Gendre JP, Galmiche JP, Danne O, Cadiot G, Lamouliatte H, Belaiche J, Mary JY. (Gastroenterology 1996 Mar;110(3):688-93.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8608877&query_hl=17&itool=pubmed_DocSum

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn’s disease. Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID).

Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, Sarfaty E, Valleur P, Dupas JL, Daurat M, Faucheron JL, Lerebours E, Michot F, Belaiche J, Jacquet N, Soule JC, Rothman N, Gendre JP,…

Identifying patients with a high risk of relapse in quiescent Crohn’s disease. The GETAID Group. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives.

Articles,1995

Sahmoud T, Hoctin-Boes G, Modigliani R, Bitoun A, Colombel JF, Soule JC, Florent C, Gendre JP, Lerebours E, Sylvester R. (Gut 1995 Dec;37(6):811-8.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8537053&query_hl=1&itool=pubmed_docsum

Treatment of Crohn’s disease by lymphocyte apheresis: a randomized controlled trial. Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives.

Articles,1994

Lerebours E, Bussel A, Modigliani R, Bastit D, Florent C, Rabian C, Rene E, Soule JC. (Gastroenterology. 1994 Aug;107(2):357-61.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8039612&query_hl=17&itool=pubmed_DocSum

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease. A prospective multicentre study of 121 cases. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives.

Articles,1994

Cellier C, Sahmoud T, Froguel E, Adenis A, Belaiche J, Bretagne JF, Florent C, Bouvry M, Mary JY, Modigliani R. (Gut. 1994 Feb;35(2):231-5.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=7508411&query_hl=17&itool=pubmed_DocSum

Oral mesalamine (Pentasa) as maintenance treatment in Crohn’s disease: a multicenter placebo-controlled study. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID).

Articles,1993

Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soule JC,Galmiche JP, Lerebours E, Descos L, Viteau JM, et al. (Gastroenterology. 1993 Feb;104(2):435-9.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8425685&query_hl=1&itool=pubmed_docsum

Clinical, biological, and endoscopic picture of attacks of Crohn’s disease. Evolution on prednisolone. Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives.

Articles,1990

Modigliani R, Mary JY, Simon JF, Cortot A, Soule JC, Gendre JP, Rene E. (Gastroenterology. 1990 Apr;98(4):811-8.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2179031&query_hl=5&itool=pubmed_docsum

Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

Articles,1989

Mary JY, Modigliani R. (Gut. 1989 Jul;30(7):983-9.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2668130&query_hl=1&itool=pubmed_docsum

Effect of levamisole on the prevention of developmental flare-ups in quiescent Crohn’s disease: a prospective multicenter controlled trial in 155 patients Gastroenterol Clin Biol.

Articles,1983

Modigliani R, Pieddeloup C, Hecketsweiler P, Descos L, Lerebours E, Vernisse B, Costil V, Bitoun A, Lacroute JM, Maire P, et al. (1983 Aug-Sep;7(8-9):683-92.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=6352383&query_hl=17&itool=pubmed_DocSum

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.

Articles,2007

Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M, Bourreille A, Duclos B, Seksik P, Mary JY, Colombel JF. (Gut. 2007 May 15) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17504943&ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

A simple biological score for predicting low risk of short-term relapse in Crohn’s disease

Articles,2006

Consigny Y, Modigliani R, Colombel JF, Dupas JL, Lémann M, Mary JY; Groupe d’Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). (IBD 2006 Jul;12(7):551-7.) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16804391&ordinalpos=13&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

Articles,2007

D’Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR. (Gastroenterology. 2007 Feb;132(2):763-86. Epub 2006 Dec 20.) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17258735&ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.

Articles,2007

Daniel F, Loriot MA, Seksik P, Cosnes J, Gornet JM, Lémann M, Fein F, Vernier-Massouille G, De Vos M, Boureille A, Treton X, Flourié B, Roblin X, Louis E, Zerbib F, Beaune P, Marteau…

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease – A randomized, double-blind, placebo-controlled GETAID trial

Articles,2006

Marteau P, Lémann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y, Cadiot G, Soulé JC, Bourreille A, Metman E, EH, Lerebours E, Carbonnel F, Dupas JL, Veyrac M, Coffin B, Moreau J, Mary…

Infliximab plus azathioprine for steroid-dependent Crohn’s disease patients: a randomized placebo-controlled trial

Articles,2006

Lemann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A, Sobahni I, Colombel JF and the GETAID. (Gastroenterology. 2006 Apr;130(4):1054-61.) https://www.ncbi.nlm.nih.gov/pubmed/16618399?dopt=Abstract

A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine

Articles,2005

Lemann M, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Modigliani R, Bouhnik Y. and GETAID. (Gastroenterology. 2005 Jun;128(7):1812-8.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15940616&query_hl=17&itool=pubmed_docsum

ITPA genotyping test does not improve detection of Crohn’s disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.

Articles,2005

Allorge D, Hamdan R, Broly F, Libersa C, Colombel JF. (Gut. 2005 Apr;54(4):565.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15753546&query_hl=31&itool=pubmed_DocSum

Small bowel adenocarcinoma in patients with Crohn’s disease compared with small bowel adenocarcinoma de novo

Articles,2005

Palascak-Juif V, Bouvier AM, Cosnes J, Flourié B, Bouché O, Cadiot G, Lémann M, Bonaz B, Denet C, Marteau P, Gambiez L, Beaugerie L, Faivre J, Carbonnel F. (IBD 2005 Sep;11(9):828-32.) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16116317&ordinalpos=20&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Clustering of Crohn’s disease within affected sibships. Eur J Hum Genet.

Articles,2003

Hugot JP, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Zouali H, Lesage S, Chamaillard M, Macry J, Thomas G,…

Tioguanine in patients with Crohn’s disease intolerant or resistant to azathioprine/mercaptopurine.

Articles,2003

Bonaz B, Boitard J, Marteau P, Lemann M, Coffin B, Flourie B, Belaiche, J Cadiot G, Metman EH, Cortot A, Colombel JF; Getaid. (Aliment Pharmacol Ther. 2003 Aug 15;18(4):401-8.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12940925&query_hl=1&itool=pubmed_docsum

Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride Aliment Pharmacol Ther

Articles,2002

Abitbol V, Mary JY, Roux C, Soule JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E, Chaussade S; Groupe D’etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). (2002 May;16(5):919-27 PMID: 11966500 [PubMed – indexed for…

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet

Articles,2002

Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS,…

CARD4/NOD1 is not involved in inflammatory bowel disease.

Zouali H, Lesage S, Merlin F, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Christensen S, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Chamaillard M, Thomas G,…

Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. Eur J Hum Genet

Zouali H, Chamaillard M, Lesage S, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Macry J, Selinger-Leneman H, Thomas G,…

Genetic analyses of chromosome 12 loci in Crohn’s disease.

Articles,2000

Lesage S, Zouali H, Colombel JF, Belaiche J, Cezard JP, Tysk C, Almer S, Gassull M, Binder V, Chamaillard M, Le Gall I, Thomas G, Hugot JP. (Gut. 2000 Dec;47(6):787-91.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11076876&query_hl=26&itool=pubmed_DocSum

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease.Nature.

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R,Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel…

Health-related quality of life in Crohn’s disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol.